Report - ANEXO I RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO · - Bilirrubina ≤ limite superior do normal (LSN) - Fosfatase alcalina ≤ 2,5 LSN (considerar as isoenzimas hepáticas 5-nucleotidase

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form